Active FOAs

Activity Code Guide Number Announcement Name Expires
Notice NOT-DK-22-003 NIDDK Encourages Research on Sex/Gender Differences, Sexual and Gender Minority-Related Research and Race/Ethnic Diversity N/A
Notice NOT-OD-22-088 The National Institutes of Health (NIH) Sexual & Gender Minority Research Office Request for Nominations for 2022 SGM Research Investigator Awards Program N/A
R01 RFA-MH-21-110 Service-Ready Tools for Identification, Prevention, and Treatment of Individuals at Risk for Suicide (R01 Clinical Trial Optional) 6/16/2022
R25 RFA-DK-22-004 NIDDK Partnerships with Professional Societies to Enhance Scientific Workforce Diversity and Promote Scientific Leadership (R25 - Clinical Trial Not Allowed) 6/22/2022
Notice NOT-MD-22-015 Administrative Supplements to Support "All of US" and Health Disparities-Related Pilot Research Projects at NIMHD-Funded Research Centers in Minority Institutions (RCMI) 6/28/2022
Notice NOT-PM-22-002 Administrative Supplements to Advance Precision Medicine Using the All of Us Research Program’s Data 7/6/2022
R01 PAR-20-079 Surgical Disparities Research (R01 - Clinical Trial Optional) 7/6/2022
U54 RFA-RM-22-008 NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST) Program: FIRST Cohort (U54 Clinical Trial Optional) 7/13/2022
U24 PAR-20-048 Building Population Health Research Capacity in the U.S. Affiliated Pacific Islands (U24 – Clinical Trial Not Allowed) 7/16/2022
Notice NOT-OD-22-125 IMPROVE Initiative: Implementation Science to Advance Maternal Health and Maternal Health Equity 7/17/2022
R01 RFA-MD-22-009 Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) 8/16/2022
UG3 PAR-20-092 Development of Medications to Prevent and Treat Opioid Use Disorders and Overdose (UG3/UH3) (Clinical Trial Optional) 9/2/2022
R01 PAR-19-297 Clinical Studies of Mental Illness (Collaborative R01 Clinical Trial Optional) 9/8/2022
R01 PAR-19-368 Accelerating the Pace of Drug Abuse Research Using Existing Data (R01 Clinical Trial Optional) 9/8/2022
U2C
RFA-DK-22-001
 
Stakeholder Engagement Innovation Center for Advancing Health Equity in Type 2 Diabetes Research (U2C - Clinical Trial Not Allowed) 10/27/2022
R01 RFA-MH-22-200 Addressing Mental Health Disparities Research Gaps: Aggregating and Mining Existing Data Sets for Secondary Analyses (R01 Clinical Trial Not Allowed) 10/19/2022
R01 RFA-AG-23-024 Policy and Alzheimer’s Disease (AD) and Alzheimer’s Disease-Related Dementias (ADRD) Healthcare Disparities: Access, Utilization, and Quality (R01 Clinical Trial Not Allowed) 10/20/2022
R01 PAR-19-372 Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) 11/9/2022
R01 PAR-19-372 Social Epigenomics Research Focused on Minority Health and Health Disparities (R01-Clinical Trial Not Allowed) 11/9/2022
R01 PAR-21-344 Interventions for Stigma Reduction to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle- Income Countries (R01 - Clinical Trial Optional) 12/21/2022
Notice NOT-MD-22-006 Research to Address Vaccine Hesitancy, Uptake, and Implementation among Populations that Experience Health Disparities 1/8/2023
R01 PAR-21-081 Addressing Health Disparities Among Immigrant Populations through Effective Interventions (R01 Clinical Trial Optional) 1/8/2023
R01 PAR-21-080 Addressing the Etiology of Health Disparities and Health Advantages Among Immigrant Populations (R01 Clinical trial not allowed) 1/8/2023
R01 PA-20-144 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R01 Clinical Trial Optional) 1/8/2023
R21 PA-20-145 Innovations in HIV Prevention, Testing, Adherence and Retention to Optimize HIV Prevention and Care Continuum Outcomes (R21 Clinical Trial Optional) 1/8/2023
R34 PA-20-141 Formative and Pilot Intervention Research for Prevention and Treatment of HIV/AIDS (R34 Clinical Trial Optional) 1/8/2023
Notice NOT-OD-22-031 Research on the Health of Women of Understudied, Underrepresented and Underreported (U3) Populations (Admin Supp Clinical Trial Optional) 2/1/2023
R01 PAR-20-310 Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Optional) 3/28/2023
R21 PAR-20-150 NIMHD Exploratory/Developmental Research Grant Program (R21 - Clinical Trial Optional) 5/8/2023
R01 PAR-20-254 Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) 7/20/2023
R01 RFA-DC-23-001 NIDCD Research Opportunities for New Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional) 8/5/2023
R01 PAR-20-273 New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial Required) 8/12/2023
R01 PA-20-172 Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) 9/8/2023
R01 PAR-20-302 Tobacco Control Policies to Promote Health Equity (R01 Clinical Trial Optional) 9/8/2023
R01 PAR-20-180 Identifying Innovative Mechanisms or Interventions that Target Multimorbidity and Its Consequences (R01 Clinical Trial Optional) 9/8/2023
R01 PA-20-172 Long-Term Effects of Disasters on Health Care Systems Serving Health Disparity Populations (R01- Clinical Trial Optional) 9/8/2023
P30 PAR-20-308 AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 9/14/2023
P30 PAR-20-307 Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional) 9/14/2023
R25 PAR-20-236 Providing Research Education Experiences to Enhance Diversity in the Next Generation of Substance Use and Addiction Scientists (R25 Clinical Trials Not Allowed) 11/16/2023
U01 PAR-21-348 The role of Epstein Barr virus (EBV) infection in Non-Hodgkin Lymphoma (NHL) and Hodgkin disease (HD) development with or without an underlying HIV infection (U01 Clinical Trial Optional) 12/16/2023
R01 RFA-DA-22-040 High Priority HIV and Substance Use Research (R01 Clinical Trial Optional) 2/16/2024
U24 RFA-ES-22-001 Maintaining and Enriching Environmental Epidemiology Cohorts to Support Scientific and Workforce Diversity (U24 Clinical Trial Not Allowed) 2/14/2024
R01 RFA-EB-21-001 Technology Development to Reduce Health Disparities (R01 Clinical Trial Optional) 5/3/2024
R34 PA-21-205 Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Drugs (R34 Clinical Trial Required) 5/8/2024
R01 PAR-22-072 Measures and Methods to Advance Research on Minority Health and Health Disparities-Related Constructs (R01 Clinical Trial Not Allowed) 5/8/2024
Notice NOT-AT-22-004  Dissemination and Implementation Research to Advance Mental, Emotional, and Behavioral Health Preventive Interventions in School Settings 6/5/2024
Notice NOT-OD-21-100 Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health 6/8/2024
R01 PAR-21-349 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) 6/22/2024
R01 PAR-21-350 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) 6/22/2024
R01 PAR-21-352 Research on Biopsychosocial Factors of Social Connectedness and Isolation on Health, Wellbeing, Illness, and Recovery (R01 Basic Experimental Studies with Humans Required) 6/22/2024
R01 PAR-22-092 Health Care Models for Persons with Multiple Chronic Conditions from Populations that Experience Health Disparities: Advancing Health Care towards Health Equity (R01 - Clinical Trials Optional) 9/8/2024
R01 PA-21-232 Comprehensive Care for Adults with Type 2 Diabetes Mellitus from Populations with Health Disparities (R01 Clinical Trial Optional) 9/8/2024
R01 PAR-21-275 The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional) 9/8/2024
K08 PAR-21-299 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 Clinical Trial Required) 9/8/2024
K08 PAR-21-300 NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) 9/8/2024
K22 PAR-21-301 NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) 9/8/2024
K22 PAR-21-302 NCI Transition Career Development Award to Promote Diversity (K22  Clinical Trial Required) 9/8/2024
R36 PAR-21-325 Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) 9/8/2024
R21 PAR-22-186 Transgender People: Immunity, Prevention, and Treatment of HIV and STIs (R21 Clinical Trial Not Allowed) 8-Dec-24
R01 PAR-21-287 Effectiveness of School-Based Health Centers to Advance Health Equity (R01 Clinical Trial Optional) 1/8/2025
R01 PAR-22-064 Patient-Clinician Relationship: Improving Health Outcomes in Populations that Experience Health Care Disparities (R01 Clinical Trial Optional) 1/8/2025
K01 PAR-22-050 NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed) 1/8/2025
K01 PAR-22-052 NIDCR Mentored Career Development Award to Promote Diversity (K01 Independent Basic Experimental Studies with Humans Required) 1/8/2025
R01 PA-21-265 Large Research Projects for Prevention of Healthcare-Associated Infections (R01) 2/7/2025
N/A PA-22-175 Competitive Revision Supplements to Existing AHRQ Grants and Cooperative Agreements to Enhance Workforce Diversity in Health Services Research 3/1/2025
Notice NOT-OD-22-106 Increasing Uptake of Evidence-Based Screening in Diverse Populations Across the Lifespan 5/8/2025
R01 PAR-22-145 Leveraging Health Information Technology (Health IT) to Address and Reduce Health Care Disparities (R01 Clinical Trial Optional) 5/8/2025
       
Past FOAs         
Activity Code Guide Number Announcement Name Expires
R01 R01PA-18-037 The Health of Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) 9/8/2018
R21 PA-18-040 The Health of Sexual and Gender Minority (SGM) Populations (R21 Clinical Trial Optional) 9/8/2018
R15 PA-18-210 The Health of Sexual and Gender Minority (SGM) Populations (R15 Clinical Trial Optional) 9/8/2018
R03 PA-18-054 The Health of Sexual and Gender Minority (SGM) Populations (R03 Clinical Trial Optional) 9/8/2018
R44 PAR-18-108 NIDDK Exploratory Clinical Trials for Small Business (R44 Clinical Trial Required) 9/6/2019
R01 PA-18-273 Targeted basic behavioral and social science and intervention development for HIV prevention and care (R01 Clinical Trial Optional) 1/8/2020
R21 PA-18-272 Targeted basic behavioral and social science and intervention development for HIV prevention and care (R21 Clinical Trial Optional) 1/8/2020
R21 RFA-MD-20-005 Methods and Measurement in Research with Sexual and Gender Minority Populations (R21 Clinical Trials Not Allowed) 3/14/2020
R01 PAS-18-557 Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 - Clinical Trials Optional) 5/8/2020
R21 PAR-19-326 Reducing Stigma to Improve HIV/AIDS Prevention, Treatment and Care in Low- and Middle-Income Countries (R21 Clinical Trial Optional) 11/13/2020
R01 PAR-18-747 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01 Clinical Trial Optional) 11/14/2020
R21 PAR-18-745 Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R21 Clinical Trial Optional) 11/14/2020
R01 PAR-20-237 Community Interventions to Address the Consequences of the COVID-19 Pandemic among Health Disparity and Vulnerable Populations (R01- Clinical Trial Optional) 12/2/2020
NOSI NOT-MD-20-022 Competitive and Administrative Supplements for Community Interventions to Reduce the Impact of COVID-19 on Health Disparity and Other Vulnerable Populations  12/30/2020
NOSI NOT-MH-20-053 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 12/30/2020
R01 PA-18-729 Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional) 1/8/2021
R21 PA-18-728 Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional) 1/8/2021
R01 PAR-18-324 Testing Interventions for Health-Enhancing Physical Activity (Clinical Trial Optional) 1/8/2021
R01 PA-18-651 Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional) 1/8/2021
R21 PA-18-652 Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed) 1/8/2021
R34 PA-18-653 Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R34 Clinical Trial Optional) 1/8/2021
R01 PAR-17-491 Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R01 Clinical Trial Optional) 1/8/2021
R21 PAR-17-490 Implementing the Most Successful Interventions to Improve HIV/AIDS Outcomes in U.S. Communities (R21 Clinical Trial Optional) 1/8/2021
R01 RFA-MD-21-002 Promoting Viral Suppression among Individuals from Health Disparity Populations Engaged in HIV Care (R01 Clinical Trial Required) 1/16/2021
R01 PAR-20-243 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) 3/3/2021
R01 PAR-20-243 Digital Healthcare Interventions to Address the Secondary Health Effects Related to Social, Behavioral, and Economic Impact of COVID-19 (R01 - Clinical Trial Optional) 3/3/2021
R01 PAR-19-018 Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R01 Clinical Trial Not Allowed) 3/5/2021
R21 PAR-19-019 Mechanisms of Disparities in Etiology and Outcomes of Lung Cancer in the U.S.: The Role of Risk and Protective Factors (R21 Clinical Trial Not Allowed) 3/5/2021
R01 PAR-19-384 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Basic Experimental Studies with Humans Required) 3/18/2021
R01 PAR-19-373 Research on biopsychosocial factors of social connectedness and isolation on health, wellbeing, illness, and recovery (R01 Clinical Trials Not Allowed) 3/18/2021
R01 PAR-19-209 Next Generation Multipurpose Prevention Technologies (NGM) (R01 Clinical Trial Optional) 5/7/2021
R01 PA-18-722 Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional) 5/8/2021
R21 PA-18-723 Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional) 5/8/2021
R36 PAR-18-894 Mental Health Research Dissertation Grant to Enhance Workforce Diversity (R36 Independent Clinical Trial Not Allowed) 5/8/2021
R01 PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) 6/16/2021
R01 PAR-18-847 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R01 - Clinical Trial Optional) 6/16/2021
R21 PAR-18-848 Electronic Nicotine Delivery Systems (ENDS): Population, Clinical and Applied Prevention Research (R21 - Clinical Trial Optional) 6/26/2021
S06 PAR-20-125 Native American Research Centers for Health (NARCH) (S06 Clinical Trials Optional) 7/21/2021
D43 PAR-19-283 Fogarty HIV Research Training Program for Low-and Middle-Income Country Institutions (D43 Clinical Trial Optional) 8/21/2021
R41 PA-18-927 Innovative Technologies for HIV Behavioral and Social Science Research (R41/R42 Clinical Trial Optional) 9/6/2021
R43 PA-18-928 Innovative Technologies for HIV Behavioral and Social Science Research (R43/R44 Clinical Trial Optional) 9/6/2021
R01 PAR-19-162 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R01-Clinical Trial Not Allowed) 9/8/2021
R21 PAR-19-163 Accelerating the Pace of Child Health Research Using Existing Data from the Adolescent Brain Cognitive Development (ABCD) Study (R21-Clinical Trial Not Allowed) 9/8/2021
R01 PA-19-042 Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional) 9/8/2021
R21 PA-19-050 Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional) 9/8/2021
R01 PAR-18-929 High-Priority Areas for Research Leveraging EHR and Large-Scale Data (R01 Clinical Trial Not Allowed) 9/8/2021
R01 PAR-19-070 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional) 11/13/2021
R21 PAR-19-071 Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Not Allowed) 11/13/2021
R01 RFA-DA-22-017 PrEP for HIV Prevention among Substance Using Populations (R01 - Clinical Trial Optional) 11/13/2021
R01 RFA-OD-19-029 The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional) 11/27/2021
U54 RFA-OD-21-010 Advancing Gender Inclusive Excellence (AGIE) – Coordinating Center (U54 - Clinical Trial Not Allowed) 12/1/2021
R01 PAR-19-093  Leveraging Health Information Technology (Health IT) to Address Minority Health and Health Disparities (R01 Clinical Trial Optional) 12/5/2021
R01 RFA-AI-21-058 American Women: Assessing Risk Epidemiologically (AWARE) (R01 Clinical Trial Optional) 12/10/2021
U01 RFA-CA-21-063 A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT; U01 Clinical Trial Optional) 12/11/2021
R01 RFA-CA-20-046 Investigation of the Transmission of Kaposi Sarcoma-Associated Herpesvirus (KSHV) (R01 Clinical Trial Optional) 12/15/2021
R34 RFA-AA-21-017 HIV Prevention and Alcohol (R34 Clinical Trials Optional) 12/17/2021
R01 RFA-AA-21-016 HIV Prevention and Alcohol (R01 Clinical Trials Optional) 12/17/2021
U24 RFA-CA-21-045 Coordinating Center for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (U24 Clinical Trial Required) 12/29/2021
UG1 RFA-CA-21-046 Research Bases for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) 12/29/2021
UG1 RFA-CA-21-047 Clinical Sites for HIV/Cervical Cancer Prevention 'CASCADE' Clinical Trials Network (UG1 Clinical Trial Required) 12/29/2021
R01 RFA-MH-22-105 Expanding Differentiated Care Approaches for Adolescents Living with HIV (R01 Clinical Trial Optional) 1/7/2022
R01 RFA-MH-22-106 Expanding Differentiated Care Approaches for Adolescents Living with HIV (R34 Clinical Trial Optional) 1/7/2022
R01 PA-18-932 Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) 1/8/2022
R15 PAR-19-135 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required) 1/8/2022
R15 PAR-19-134 Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed) 1/8/2022
R01 PA-18-932 Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional) 1/8/2022
R01 RFA-MD-22-001 Innovative Multi-Level Approaches and Strategies to Prevent, Test and Treat HIV in Primary Care Settings in Health Disparity Populations in Geographic Hot Spots in the United States (R01 - Clinical Trial Required) 1/15/2022
P50 PAR-20-286 Practice-Based Suicide Prevention Research Centers (P50 Clinical Trial Optional) 1/27/2022
U24 RFA-DA-22-033 Coordinating Center for the HIV/AIDS and Substance Use Cohorts Program (U24 - Clinical Trial Not Allowed) 2/18/2022
R34 RFA-MH-22-125 Enhanced Interpersonal Focused Strategies for Suicide Prevention Interventions (R34 Clinical Trial Required) 2/19/2022
U01 PAR-20-118 National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U01 Clinical Trial Optional) 3/26/2022
U19 PAR-20-119 National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental or Substance Use Disorders or Alcohol Disorder (U19 Clinical Trial Optional) 3/26/2022
U24 RFA-CA-22-014 Data, Evaluation and Coordinating Center for: A Multilevel Approach to Connecting Underrepresented Populations to Clinical Trials (CUSP2CT) (U24 Clinical Trial Not Allowed) 3/29/2022
UM2 RFA-HD-23-020 Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Scientific Leadership Center (UM2 Clinical Trial Optional) 4/1/2022
UM2 RFA-HD-23-021 Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) Operations and Collaborations Center (UM2 Clinical Trial Optional) 4/1/2022
R01 PAR-20-088 Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R01- Clinical Trial Not Allowed) 4/2/2022
R21 PAR-20-081 Mechanisms of Disparities in Chronic Liver Diseases and Cancer (R21- Clinical Trial Not Allowed) 4/2/2022
R43/R44 RFA-MD-22-004 Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional) 4/5/2022
R41/R42  RFA-MD-22-003 Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional) 4/5/2022
R01 RFA-NR-22-001 Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) 4/8/2022
R01 RFA-NR-22-002 Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) 4/8/2022
R01 RFA-NR-22-003 Evaluating the Impact of COVID-19 Pandemic-related Food and Housing Policies and Programs on Health Outcomes in Health Disparity Populations (R01 Clinical Trial Optional) 4/8/2022
U01 RFA-OD-22-006 Emergency Award: RADx-UP Community-Engaged Research on Rapid SARS-CoV-2 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) 5/3/2022
U01 RFA-OD-22-005 Emergency Awards: RADx®-UP - Social, Ethical, and Behavioral Implications (SEBI) Research on Disparities in COVID-19 Testing among Underserved and Vulnerable Populations (U01 Clinical Trial Optional) 5/3/2022
R01 PAR-19-236 Reducing the Duration of Untreated Psychosis in the United States (R01 Clinical Trial Required) 5/8/2022
R01 RFA-MH-22-170 Advancing communication strategies to support future HIV vaccine use (R01 Clinical Trial Optional) 5/11/2022
R21 RFA-MH-22-171 Advancing communication strategies to support future HIV vaccine use (R21 Clinical Trial Optional) 5/11/2022
U01 RFA-RM-21-022 Limited Competition: Transformative Research to Address Health Disparities and Advance Health Equity at Minority Serving Institutions (U01 Clinical Trial Optional) 5/24/2022
R25 PAR-20-080 NIMH Mentoring Networks for Mental Health Research Education (R25 Clinical Trial Not Allowed) 5/26/2022
R25 RFA-LM-22-001 Short-Term Research Education Experiences to Attract Talented Students to Biomedical Informatics/Data Science Careers and Enhance Diversity (R25 Clinical Trial Not Allowed) 6/1/2022

This page last reviewed on June 14, 2022